Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.
Brief Summary: This trial is conducted in Europe. The trial is designed to show the effect of treatment with liraglutide or placebo on blood glucose control after 14 weeks in subjects with type 2 diabetes. Liraglutide or placebo is administered by injection once daily in the evening. The trial is a multi-national trial with treatment concealed to participating subjects, investigators and the sponsor. Treatment allocation is random with equal chance of being assigned to each group.


Options:
A: Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: rosiglitazone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: glimepiride; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): N/A
C: Arm Label: Lira 0.6 + Met; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: metformin, Drug: placebo | Arm Label: Lira 1.2 + Met; Type: EXPERIMENTAL; Interventions: Drug: metformin, Drug: placebo, Drug: liraglutide | Arm Label: Lira 1.8 + Met; Type: EXPERIMENTAL; Interventions: Drug: metformin, Drug: placebo, Drug: liraglutide | Arm Label: Met Mono; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin, Drug: placebo | Arm Label: Met + Glim; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin, Drug: glimepiride, Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 0.6 + Met | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): Lira 0.6 + Met, Lira 1.2 + Met, Lira 1.8 + Met, Met + Glim, Met Mono | Intervention Type: DRUG; Name: glimepiride; Assigned to Arm(s): Met + Glim | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Lira 0.6 + Met, Lira 1.2 + Met, Lira 1.8 + Met, Met Mono | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Met + Glim, Met Mono | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.2 + Met | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.8 + Met
D: Arm Label: Lira 1.2 mg -> Lira 1.2 mg -> Lira 1.2 mg; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: metformin | Arm Label: Lira 1.8 mg -> Lira 1.8 mg -> Lira 1.8 mg; Type: EXPERIMENTAL; Interventions: Drug: metformin, Drug: liraglutide | Arm Label: Sita -> Sita; Type: ACTIVE_COMPARATOR; Interventions: Drug: sitagliptin, Drug: metformin | Arm Label: Sita -> Sita -> Lira 1.2 mg; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: sitagliptin, Drug: metformin | Arm Label: Sita -> Sita -> Lira 1.8 mg; Type: EXPERIMENTAL; Interventions: Drug: sitagliptin, Drug: metformin, Drug: liraglutide | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.2 mg -> Lira 1.2 mg -> Lira 1.2 mg, Sita -> Sita -> Lira 1.2 mg | Intervention Type: DRUG; Name: sitagliptin; Assigned to Arm(s): Sita -> Sita, Sita -> Sita -> Lira 1.2 mg, Sita -> Sita -> Lira 1.8 mg | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): Lira 1.2 mg -> Lira 1.2 mg -> Lira 1.2 mg, Lira 1.8 mg -> Lira 1.8 mg -> Lira 1.8 mg, Sita -> Sita, Sita -> Sita -> Lira 1.2 mg, Sita -> Sita -> Lira 1.8 mg | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.8 mg -> Lira 1.8 mg -> Lira 1.8 mg, Sita -> Sita -> Lira 1.8 mg

Answer: B